The Anti-erbB3 Antibody MM-121/SAR256212 in Combination With Trastuzumab Exerts Potent Antitumor Activity Against Trastuzumab-Resistant Breast Cancer Cells
Molecular Cancer- United Kingdom
doi 10.1186/1476-4598-12-134
Full Text
Abstract
Available in
Date
January 1, 2013
Authors
Publisher
Springer Science and Business Media LLC